Type II diabetics: Be warned!

A type II diabetic has to be diligent.

In order to maintain good health, he has to curb his diet and get regular exercise. But he also has to constantly be on guard to avoid mainstream blather about diabetes medications.

If you happen to be a type II diabetic, please take a moment to power up your malarkey detector because you're going to need it to make sense of some mainstream commentary about the newest study that examines a common drug used to treat diabetes.  Which is also unsafe.

How do I know this drug is unsafe? Easy. I went to the pharmaceutical company's website, and right there on the home page I found this: "... can cause or worsen heart failure".

Can't say they didn't warn us.

In the new study (published in the Lancet and presented at the annual meeting of the American Diabetes Association), more than 4,400 type II diabetics were divided into two groups to receive the drug containing rosiglitazone, or a combination of two other popular type II diabetes drugs (metformin and sulfonylurea) for about five years.

The results: "Addition of rosiglitazone to glucose-lowering therapy in people with type II diabetes is confirmed to increase the risk of heart failure and of some fractures, mainly in women".

Discouraging? Not a bit. Here's how Dr. Philip D. Home (lead author of the study) put a fresh coat of happy sunshine on the results: "The findings essentially are that, in overall cardiovascular terms, the drug is safe".

Okay – let's consult the malarkey detector. On a 1-10 scale, Dr. Home's comment rates...Yes! A perfect 10! Well done, Dr. Home!

You might wonder how Dr. Home figures the drug is "safe" when his study has just confirmed increased heart failure risk. Maybe it's because in the "interpretation" of the study, he and the other authors state that rosiglitazone did not increase the risk of cardiovascular illness or death compared to the other two drugs.

And yet, in the study "findings", here's how they put it: "Heart failure causing admission to hospital or death occurred in 61 people in the rosiglitazone group and 29 in the active control group".

Once again – the malarkey detector gives it...another perfect 10.

See what I mean? Without a reliable way to assess grade-A malarkey, a type II diabetic might read Dr. Home's comments and come away believing the drug is no more dangerous than pure spring water.

Your hit parade

There is also this warning posted on the FDA web site: When [this drug] is taken with other oral diabetes medicines, there's a risk of "blood sugar becoming dangerously low".

And of course our old friend Dr. David Graham has weighed in on rosiglitazone.

Dr. Graham is an FDA drug safety scientist who has consistently been 100% malarkey-free in his assessment of dangerous drugs – earning him an odd-man-out status at the agency. Dr. Graham told the Associated Press that keeping rosiglitazone on the market "makes no medical sense and violated the principle taught us all in medical school...First, do no harm".

Unfortunately, when Dr. Graham speaks, the FDA rarely listens.

If you're a diabetic who's taking a form of rosiglitazone, or if someone you care about is taking the drug, you can easily find information about non-drug methods for managing blood sugar click here.

But please be sure to talk to your doctor before making any changes in your current regimen.